PL1948782T3 - Adiuwanty szczepionki - Google Patents
Adiuwanty szczepionkiInfo
- Publication number
- PL1948782T3 PL1948782T3 PL06744545T PL06744545T PL1948782T3 PL 1948782 T3 PL1948782 T3 PL 1948782T3 PL 06744545 T PL06744545 T PL 06744545T PL 06744545 T PL06744545 T PL 06744545T PL 1948782 T3 PL1948782 T3 PL 1948782T3
- Authority
- PL
- Poland
- Prior art keywords
- vaccine adjuvants
- vaccine
- adjuvants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN505MU2005 | 2005-04-25 | ||
EP06744545A EP1948782B8 (en) | 2005-04-25 | 2006-04-21 | Vaccine adjuvants |
PCT/IB2006/000978 WO2006114680A2 (en) | 2005-04-25 | 2006-04-21 | Vaccine adjuvants |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1948782T3 true PL1948782T3 (pl) | 2013-01-31 |
Family
ID=37215117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06744545T PL1948782T3 (pl) | 2005-04-25 | 2006-04-21 | Adiuwanty szczepionki |
Country Status (10)
Country | Link |
---|---|
US (2) | US8048434B2 (pl) |
EP (1) | EP1948782B8 (pl) |
AP (1) | AP2695A (pl) |
AU (1) | AU2006238906B2 (pl) |
CA (1) | CA2632353C (pl) |
EA (1) | EA200800917A1 (pl) |
ES (1) | ES2388684T3 (pl) |
GB (1) | GB2442408B (pl) |
PL (1) | PL1948782T3 (pl) |
WO (1) | WO2006114680A2 (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2463434B (en) * | 2007-06-28 | 2013-01-30 | Cadila Pharmaceuticals Ltd | Mitogen activated protein kinase modulator |
WO2011083493A1 (en) * | 2010-01-08 | 2011-07-14 | National Institute Of Immunology | Human chorionic gonadotropin (hcg) based vaccine for prevention and treatment of cancer |
US20180042850A1 (en) * | 2010-02-19 | 2018-02-15 | Cadila Pharmaceuticals Ltd. | Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity |
ES2648139T3 (es) * | 2010-02-19 | 2017-12-28 | Cadila Pharmaceuticals Ltd. | Una composición farmacéutica de células muertas con inmunogenicidad sustancialmente retenida |
CA2828401C (en) * | 2011-02-28 | 2023-01-10 | Cadila Pharmaceuticals Limited | Therapeutic cancer vaccine |
WO2013005164A2 (en) * | 2011-07-05 | 2013-01-10 | Cadila Pharmaceuticals Limited | Cancer antigen |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643565A (en) | 1985-09-20 | 1997-07-01 | Chiron Corporation | Human IL-2 as a vaccine adjuvant |
US6355256B1 (en) | 1994-09-30 | 2002-03-12 | Ludwig Institute For Cancer Research | Compositions containing a p53 derived protein or peptide, an adjuvant, and interleukin-12 and uses thereof |
SE9403526D0 (sv) | 1994-10-14 | 1994-10-14 | Astra Ab | New Peptides |
SE9501067D0 (sv) | 1995-03-24 | 1995-03-24 | Astra Ab | New peptides |
JP4104186B2 (ja) | 1995-11-30 | 2008-06-18 | 財団法人化学及血清療法研究所 | オイルアジュバントワクチンおよびその調製方法 |
US6231859B1 (en) | 1996-12-02 | 2001-05-15 | Aquila Biopharmaceuticals, Inc. | Saponin adjuvant compositions |
CU22629A1 (es) | 1997-03-06 | 2000-12-22 | Ct Ingenieria Genetica Biotech | Formulaciones inmunopotenciadoras para uso vacunal |
JPH11106351A (ja) | 1997-10-02 | 1999-04-20 | Chemo Sero Therapeut Res Inst | オイルアジュバントワクチンおよびその製造方法 |
US6306404B1 (en) | 1998-07-14 | 2001-10-23 | American Cyanamid Company | Adjuvant and vaccine compositions containing monophosphoryl lipid A |
JP2001131087A (ja) | 1999-11-05 | 2001-05-15 | Chemo Sero Therapeut Res Inst | オイルアジュバントワクチン |
DE60231605D1 (de) * | 2001-01-17 | 2009-04-30 | Bakulesh Mafatlal Khamar | Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen |
UA79952C2 (en) * | 2001-12-10 | 2007-08-10 | Kabulesh Mafatlal Khamar | MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT |
GB2392839A (en) * | 2002-03-08 | 2004-03-17 | Bakulesh Mafatlal Khamar | Use of Mycobacterium w in the treatment of tuberculosis |
-
2006
- 2006-04-21 PL PL06744545T patent/PL1948782T3/pl unknown
- 2006-04-21 ES ES06744545T patent/ES2388684T3/es active Active
- 2006-04-21 CA CA2632353A patent/CA2632353C/en not_active Expired - Fee Related
- 2006-04-21 EA EA200800917A patent/EA200800917A1/ru unknown
- 2006-04-21 AU AU2006238906A patent/AU2006238906B2/en not_active Ceased
- 2006-04-21 AP AP2008004362A patent/AP2695A/xx active
- 2006-04-21 GB GB0801474A patent/GB2442408B/en not_active Expired - Fee Related
- 2006-04-21 US US10/583,731 patent/US8048434B2/en not_active Expired - Fee Related
- 2006-04-21 EP EP06744545A patent/EP1948782B8/en not_active Not-in-force
- 2006-04-21 WO PCT/IB2006/000978 patent/WO2006114680A2/en active Application Filing
-
2011
- 2011-09-23 US US13/242,909 patent/US8277778B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2632353A1 (en) | 2006-11-02 |
CA2632353C (en) | 2018-02-20 |
AU2006238906A1 (en) | 2006-11-02 |
US20120014985A1 (en) | 2012-01-19 |
AP2695A (en) | 2013-07-16 |
US20080131458A1 (en) | 2008-06-05 |
EA200800917A1 (ru) | 2008-12-30 |
AU2006238906B2 (en) | 2013-04-11 |
GB2442408B (en) | 2010-06-30 |
US8048434B2 (en) | 2011-11-01 |
WO2006114680A8 (en) | 2008-08-14 |
US8277778B2 (en) | 2012-10-02 |
EP1948782A2 (en) | 2008-07-30 |
EP1948782B1 (en) | 2012-08-01 |
EP1948782B8 (en) | 2012-09-12 |
WO2006114680A3 (en) | 2007-08-23 |
GB0801474D0 (en) | 2008-03-05 |
WO2006114680A2 (en) | 2006-11-02 |
GB2442408A (en) | 2008-04-02 |
ES2388684T3 (es) | 2012-10-17 |
EP1948782A4 (en) | 2009-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL192084A0 (en) | Vaccine | |
GB0504436D0 (en) | Vaccine | |
GB0417494D0 (en) | Vaccine | |
GB0409940D0 (en) | Vaccine | |
GB0805675D0 (en) | Adjuvanted vaccine | |
AP2695A (en) | Vaccine adjuvants | |
GB0411150D0 (en) | Vaccine | |
GB0515135D0 (en) | Vaccine | |
ZA200709207B (en) | Vaccine | |
GB2443591B (en) | Adjuvanted vaccine | |
GB0516944D0 (en) | Vaccine | |
GB0413510D0 (en) | Vaccine | |
GB0810662D0 (en) | Vaccine | |
ZA200709210B (en) | Vaccine | |
GB0412407D0 (en) | Vaccine | |
GB0526412D0 (en) | Vaccine | |
GB0406598D0 (en) | Vaccine | |
GB0419918D0 (en) | Vaccine | |
GB0419838D0 (en) | Vaccine adjuvants | |
GB0513194D0 (en) | Vaccine | |
GB0514021D0 (en) | Vaccine | |
IL186586A0 (en) | Vaccine | |
GB0521164D0 (en) | Vaccine | |
GB0513189D0 (en) | Vaccine | |
GB0511475D0 (en) | Vaccine |